(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ASIAN MYELOMA NETWORK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ASIAN MYELOMA NETWORK

ST13

US500000086459354

Class

35, 41

Filing

86459354

Registration

4733548

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/27/2024

Trademark type

Word

Nice classes

35, 41

Filing date

11/19/2014

Registration date

05/05/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/27/2024

Last transaction

08/27/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

First use anywhere

2011-03-00

First use in commerce

2011-03-00

Drawing code

4

Owner type

03

Owner location

Studio City, CA, US

Examiner

BAKER, JORDAN A

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

I. F. (pessoa física)
I. F. (pessoa física)

Representatives

Natasha Shabani GREENBERG GLUSKER FIELDS CLAMAN & MACHTINGER LLP

Technical classification

Nice Classes

Class 35Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Association servicespromoting public awareness of myeloma researchdiagnosis and treatment; Association servicespromoting the public interest and awareness in cancer research and education; Promoting collaboration within the scientificresearch and provider communities to achieve advances in the field of myeloma researchdiagnosis and treatment

Class 41

Arranging and conducting educational conferences; Education servicesproviding classesseminars and workshops in the field of myeloma researchdiagnosis and treatment

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/27/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/27/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/27/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/27/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

06/13/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/26/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/26/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/26/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

12/07/2020

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

12/07/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/10/2020

ES8R

TEAS SECTION 8 RECEIVED

08/13/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/05/2018

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

05/05/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/31/2015

ALIE

ASSIGNED TO LIE

03/31/2015

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/12/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

03/11/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/11/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

03/11/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/11/2015

DOCK

ASSIGNED TO EXAMINER

03/09/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/26/2014

NWAP

NEW APPLICATION ENTERED

11/22/2014

Continuous trademark protection

Get notified about every new filing that threatens ASIAN MYELOMA NETWORK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.